11677

532612

INDOCO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

INDOCO REMEDIES LTD. Share Price Today

INDOCO REMEDIES LTD. is currently trading at ₹231, down by ₹6.19 from the previous close. The stock touched an intraday high of ₹242.99 and a low of ₹229.50 during the latest trading session. Over the past one year, INDOCO REMEDIES LTD. has delivered a loss of 20.65%, while the stock has gained 18.32% in the last one month.

INDOCO REMEDIES LTD. performance

Today’s low Today’s high
₹ 229.50 ₹ 242.99
₹ 231.60
52 week low 52 week high
₹ 162.19 ₹ 349.80
₹ 231.60
Open Price ₹ 237.00
Prev. Close ₹ 237.20
Volume (Shares) 142751.00
Total traded value ₹ 330.61
Upper Circuit ₹ 284.64
Lower Circuit ₹ 189.76
info

Investment Returns

Over 1 Month 18.32% Over 3 Months 24.58% Over 6 Months 2.50% Over 1 Year -20.65%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

INDOCO REMEDIES LTD. fundamentals


  • Market cap (Cr) 2,137.80
  • P/E Ratio (TTM) -378.77
  • Beta 0.98
  • Book Value / share 119.08
  • Return on equity -0.89%
  • EPS (TTM) 0.00
  • Dividend yield 0.09%
  • Net profit/quarter (Cr) 27.35
info icon alternate text
  • Market cap (Cr) 2,132.70
  • P/E Ratio (TTM) -378.77
  • Beta 0.75
  • Book Value / share 119.08
  • Return on equity -0.89%
  • EPS (TTM) 0.00
  • Dividend yield 0.09%
  • Net profit/quarter (Cr) 27.35
info icon alternate text

INDOCO REMEDIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 429.06
Operating Expense 435.54
Net Profit 27.35
Net Profit Margin (%) 6.37
Earnings Per Share (EPS) 2.96
EBITDA 77.06
Effective Tax Rate (%) 0.97
Particulars DEC 2025 (Values in Cr)
Revenue 389.57
Operating Expense 422.12
Net Profit -20.00
Net Profit Margin (%) -5.13
Earnings Per Share (EPS) -2.17
EBITDA 27.06
Effective Tax Rate (%) 2.20
Particulars SEP 2025 (Values in Cr)
Revenue 429.30
Operating Expense 438.37
Net Profit 15.05
Net Profit Margin (%) 3.50
Earnings Per Share (EPS) 1.63
EBITDA 59.40
Effective Tax Rate (%) -54.20
Particulars JUN 2025 (Values in Cr)
Revenue 383.83
Operating Expense 426.51
Net Profit -28.06
Net Profit Margin (%) -7.31
Earnings Per Share (EPS) -3.04
EBITDA 20.41
Effective Tax Rate (%) 1.19
Particulars MAR 2025 (Values in Cr)
Revenue 341.07
Operating Expense 384.65
Net Profit -26.24
Net Profit Margin (%) -7.69
Earnings Per Share (EPS) -2.85
EBITDA 9.96
Effective Tax Rate (%) 15.08
Particulars MAR 2026 (Values in Cr)
Revenue 1633.54
Operating Expense 1724.32
Net Profit -5.66
Net Profit Margin (%) -0.34
Earnings Per Share (EPS) -0.61
EBITDA 183.93
Effective Tax Rate (%) 50.65
Particulars MAR 2025 (Values in Cr)
Revenue 1494.78
Operating Expense 1545.03
Net Profit -8.73
Net Profit Margin (%) -0.58
Earnings Per Share (EPS) -0.95
EBITDA 147.51
Effective Tax Rate (%) -18.45
Particulars MAR 2024 (Values in Cr)
Revenue 1761.95
Operating Expense 1657.62
Net Profit 116.64
Net Profit Margin (%) 6.61
Earnings Per Share (EPS) 12.66
EBITDA 278.02
Effective Tax Rate (%) 23.87
Particulars MAR 2023 (Values in Cr)
Revenue 1638.13
Operating Expense 1477.43
Net Profit 141.36
Net Profit Margin (%) 8.62
Earnings Per Share (EPS) 15.34
EBITDA 287.22
Effective Tax Rate (%) 26.21
Particulars MAR 2022 (Values in Cr)
Revenue 1502.70
Operating Expense 1305.81
Net Profit 154.52
Net Profit Margin (%) 10.28
Earnings Per Share (EPS) 16.77
EBITDA 329.32
Effective Tax Rate (%) 34.58
Particulars MAR 2025 (Values in Cr)
Book Value / Share 110.79
ROE % -7.31
ROCE % -0.42
Total Debt to Total Equity 0.78
EBITDA Margin 6.35
Particulars MAR 2024 (Values in Cr)
Book Value / Share 120.40
ROE % 9.07
ROCE % 10.76
Total Debt to Total Equity 0.47
EBITDA Margin 14.62
Particulars MAR 2023 (Values in Cr)
Book Value / Share 111.58
ROE % 14.72
ROCE % 16.74
Total Debt to Total Equity 0.30
EBITDA Margin 17.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 98.17
ROE % 18.50
ROCE % 22.08
Total Debt to Total Equity 0.31
EBITDA Margin 21.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 83.45
ROE % 12.85
ROCE % 15.06
Total Debt to Total Equity 0.36
EBITDA Margin 18.31
Particulars MAR 2025 (Values in Cr)
Book Value / Share 119.61
ROE % -0.89
ROCE % 2.68
Total Debt to Total Equity 0.57
EBITDA Margin 9.64
Particulars MAR 2024 (Values in Cr)
Book Value / Share 122.22
ROE % 10.83
ROCE % 12.31
Total Debt to Total Equity 0.39
EBITDA Margin 15.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 111.45
ROE % 14.64
ROCE % 16.66
Total Debt to Total Equity 0.31
EBITDA Margin 17.23
Particulars MAR 2022 (Values in Cr)
Book Value / Share 98.13
ROE % 18.47
ROCE % 22.07
Total Debt to Total Equity 0.31
EBITDA Margin 21.39
Particulars MAR 2021 (Values in Cr)
Book Value / Share 83.44
ROE % 12.75
ROCE % 15.00
Total Debt to Total Equity 0.36
EBITDA Margin 18.28
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 17.06
Total Assets 2429.91
Total Liabilities 2429.91
Total Equity 1018.37
Share Outstanding 9
Price to Book Ratio 1.95
Return on Assets (%) -3.03
Return on Capital (%) -3.69
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 24.32
Total Assets 2144.72
Total Liabilities 2144.72
Total Equity 1110.49
Share Outstanding 9
Price to Book Ratio 2.69
Return on Assets (%) 4.59
Return on Capital (%) 5.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 13.33
Total Assets 1658.19
Total Liabilities 1658.19
Total Equity 1028.25
Share Outstanding 9
Price to Book Ratio 2.92
Return on Assets (%) 8.57
Return on Capital (%) 10.59
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 19.77
Total Assets 1486.09
Total Liabilities 1486.09
Total Equity 904.64
Share Outstanding 9
Price to Book Ratio 3.84
Return on Assets (%) 10.41
Return on Capital (%) 13.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 14.33
Total Assets 1315.06
Total Liabilities 1315.06
Total Equity 768.99
Share Outstanding 9
Price to Book Ratio 3.46
Return on Assets (%) 7.07
Return on Capital (%) 9.05
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 12.03
Total Assets 2201.16
Total Liabilities 2201.16
Total Equity 1103.35
Share Outstanding 9
Price to Book Ratio 1.95
Return on Assets (%) -0.39
Return on Capital (%) -0.47
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 16.93
Total Assets 1960.60
Total Liabilities 1960.60
Total Equity 1126.61
Share Outstanding 9
Price to Book Ratio 2.69
Return on Assets (%) 5.94
Return on Capital (%) 7.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.39
Total Assets 1659.67
Total Liabilities 1659.67
Total Equity 1027.02
Share Outstanding 9
Price to Book Ratio 2.92
Return on Assets (%) 8.51
Return on Capital (%) 10.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 19.20
Total Assets 1487.56
Total Liabilities 1487.56
Total Equity 904.30
Share Outstanding 9
Price to Book Ratio 3.84
Return on Assets (%) 10.38
Return on Capital (%) 13.45
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 14.05
Total Assets 1316.56
Total Liabilities 1316.56
Total Equity 768.92
Share Outstanding 9
Price to Book Ratio 3.46
Return on Assets (%) 7.01
Return on Capital (%) 9.41
Particulars MAR 2025 (Values in Cr)
Net Income -75.36
Cash from Operations 111.05
Cash from Investing -339.11
Cash from Financing 241.42
Net change in Cash -2.75
Free Cash Flow 467.20
Particulars MAR 2024 (Values in Cr)
Net Income 124.27
Cash from Operations 173.34
Cash from Investing -432.51
Cash from Financing 280.43
Net change in Cash 3.30
Free Cash Flow 599.33
Particulars MAR 2023 (Values in Cr)
Net Income 192.79
Cash from Operations 240.48
Cash from Investing -208.17
Cash from Financing 22.80
Net change in Cash -6.54
Free Cash Flow 447.73
Particulars MAR 2022 (Values in Cr)
Net Income 236.57
Cash from Operations 214.90
Cash from Investing -121.40
Cash from Financing -44.37
Net change in Cash 8.04
Free Cash Flow 340.23
Particulars MAR 2021 (Values in Cr)
Net Income 131.99
Cash from Operations 101.94
Cash from Investing -66.69
Cash from Financing -29.87
Net change in Cash -14.34
Free Cash Flow 178.78
Particulars MAR 2025 (Values in Cr)
Net Income -8.37
Cash from Operations 106.36
Cash from Investing -259.79
Cash from Financing 168.62
Net change in Cash -0.40
Free Cash Flow 364.79
Particulars MAR 2024 (Values in Cr)
Net Income 141.69
Cash from Operations 194.36
Cash from Investing -301.70
Cash from Financing 122.40
Net change in Cash -2.51
Free Cash Flow 373.39
Particulars MAR 2023 (Values in Cr)
Net Income 191.59
Cash from Operations 240.17
Cash from Investing -208.51
Cash from Financing 22.80
Net change in Cash -6.91
Free Cash Flow 429.56
Particulars MAR 2022 (Values in Cr)
Net Income 236.23
Cash from Operations 214.53
Cash from Investing -121.41
Cash from Financing -44.36
Net change in Cash 7.77
Free Cash Flow 339.86
Particulars MAR 2021 (Values in Cr)
Net Income 131.35
Cash from Operations 101.92
Cash from Investing -66.69
Cash from Financing -29.82
Net change in Cash -14.35
Free Cash Flow 178.77
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 31.51 13.02 1.52 241.47 23.12 38.85
BLISS GVS PHARMA LTD. 492.50 39.98 4.37 5223.27 118.35 495.00
CIPLA LTD. 1440.30 30.57 3.37 116353.96 1165.55 1672.20
FERMENTA BIOTECH LTD. 365.50 16.12 2.64 1075.70 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 31.51 22.03 4.05 241.47 23.12 38.85
AMRUTAJAN HEALTH LTD 538.05 24.12 4.20 1555.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8382.65 109.48 24.01 20956.63 7630.00 9850.00
BLISS GVS PHARMA LTD. 492.50 53.13 4.52 5223.27 118.35 495.00

INDOCO REMEDIES LTD. shareholding pattern

Holding
22.04%
58.86%
0.94%
18.15%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

INDOCO REMEDIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
231.60 -2.36 redarrow
red-green-graph indicator
7 Bearish
9 Bullish
  • 5 Days 234.30
  • 26 Days 224.30
  • 10 Days 232.20
  • 50 Days 218.70
  • 12 Days 230.90
  • 100 Days 218.70
  • 20 Days 226.60
  • 200 Days 232.30
237.89 PIVOT
First Support 235.37 First Resistance 239.71 Second Support 233.55 Second Resistance 242.23 Third Support 231.03 Third Resistance 244.05
RSI 55.77 ADX 27.62 MACD 6.66 Williams % R -47.26 Commodity Channel Index (CCI) 49.34
Date 2026-06-25 Week 38903.00 Same Day 44024.00 Month 171070.00
1 Year 0.98 3 Year 0.86
Over 1 Month
18.32% down
Over 1 Year
-20.65% down
Over 3 Months
24.58% down
Over 3 Years
-11.07% down
Over 6 Months
2.50% down
Over 5 Years
-9.98% down

INDOCO REMEDIES LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
04 Sep 2025 0.2 Final 04 Sep 2025 Equity shares
19 Sep 2024 1.5 Final 19 Sep 2024 Equity shares
18 Sep 2023 2.25 Final 19 Sep 2023 Equity shares
14 Sep 2022 0.75 Special 16 Sep 2022 Equity shares
14 Sep 2022 1.5 Final 15 Sep 2022 Equity shares
17 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
18 Sep 2020 0.3 Final 22 Sep 2020 Equity shares
22 Aug 2019 0.3 Final 26 Aug 2019 Equity shares
31 Aug 2018 1.0 Final 04 Sep 2018 Equity shares
31 Jul 2017 1.6 Final 02 Aug 2017 Equity shares
20 Jul 2016 0.2 Final 22 Jul 2016 Equity shares
17 Mar 2016 1.4 Interim 18 Mar 2016 Equity shares
21 Jul 2015 1.6 Final 23 Jul 2015 Equity shares
21 Jul 2014 1.4 Final 23 Jul 2014 Equity shares
19 Jul 2013 1.1 Final 23 Jul 2013 Equity shares
20 Jul 2012 1.1 Final 24 Jul 2012 Equity shares
19 Jul 2011 8.0 Final 21 Jul 2011 Equity shares
13 Jul 2010 7.0 Final 15 Jul 2010 Equity shares
09 Sep 2009 2.0 Final 11 Sep 2009 Equity shares
11 Dec 2008 3.25 Interim 12 Dec 2008 Equity shares
19 Sep 2008 5.0 Final 23 Sep 2008 Equity shares
13 Dec 2007 6.5 Final 15 Dec 2007 Equity shares
15 Sep 2005 0.0 Final 17 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
17 May 2012 17 May 2012 1:2
Ex-Date Old FV NEW FV Record Date
17 May 2012 10.0 2.0 19 May 2012
Dividend date Dividend amount Dividend type Record date Instrument type
04 Sep 2025 0.2 Final 04 Sep 2025 Equity shares
19 Sep 2024 1.5 Final 19 Sep 2024 Equity shares
18 Sep 2023 2.25 Final 19 Sep 2023 Equity shares
14 Sep 2022 0.75 Special 16 Sep 2022 Equity shares
14 Sep 2022 1.5 Final 15 Sep 2022 Equity shares
17 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
18 Sep 2020 0.3 Final 22 Sep 2020 Equity shares
22 Aug 2019 0.3 Final 26 Aug 2019 Equity shares
31 Aug 2018 1.0 Final 04 Sep 2018 Equity shares
31 Jul 2017 1.6 Final 02 Aug 2017 Equity shares
20 Jul 2016 0.2 Final 22 Jul 2016 Equity shares
17 Mar 2016 1.4 Interim 18 Mar 2016 Equity shares
21 Jul 2015 1.6 Final 23 Jul 2015 Equity shares
21 Jul 2014 1.4 Final 23 Jul 2014 Equity shares
19 Jul 2013 1.1 Final 23 Jul 2013 Equity shares
20 Jul 2012 1.1 Final 24 Jul 2012 Equity shares
19 Jul 2011 8.0 Final 21 Jul 2011 Equity shares
13 Jul 2010 7.0 Final 15 Jul 2010 Equity shares
09 Sep 2009 2.0 Final 11 Sep 2009 Equity shares
11 Dec 2008 3.25 Interim 12 Dec 2008 Equity shares
19 Sep 2008 5.0 Final 23 Sep 2008 Equity shares
13 Dec 2007 6.5 Final 15 Dec 2007 Equity shares
15 Sep 2005 0.0 Final 17 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
17 May 2012 17 May 2012 1:2
Ex-Date Old FV NEW FV Record Date
17 May 2012 10.0 2.0 19 May 2012

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Indoco Remedies Ltd?

Answer Field

Indoco Remedies Ltd share price is for NSE ₹ 231.00 & for BSE ₹ 232.85 as on Jun 25 2026 03:29 PM.

What is the Market Cap of Indoco Remedies Ltd Share?

Answer Field

The market cap of Indoco Remedies Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 25 2026 03:29 PM.

What is the 52 Week High and Low of Indoco Remedies Ltd?

Answer Field

The 52 Week High and Low of Indoco Remedies Ltd for NSE is ₹ 349.80 and ₹ 162.19 and for BSE is ₹ 348.10 and ₹ 163.70.

What is 1 year return for Indoco Remedies Ltd?

Answer Field

The 1 year returns on the stock has been -20.65%.

What is the P/E Ratio of Indoco Remedies Ltd Share?

Answer Field

As on Jun 25 2026 03:29 PM the price-to-earnings (PE) ratio for Indoco Remedies Ltd share is -378.77.

What is the PB ratio of Indoco Remedies Ltd Share?

Answer Field

As on Jun 25 2026 03:29 PM, the price-to-book (PB) ratio for Indoco Remedies Ltd share is 119.08.

How to Buy Indoco Remedies Ltd Share?

Answer Field

You can trade in Indoco Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Indoco Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Indoco Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Indoco Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|